Nemaura Medical Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Nemaura Medical last-minute Real Value cannot be determined due to lack of data. The latest price of Nemaura Medical is $0.0. Our model forecasts the value of Nemaura Medical from analyzing the firm fundamentals such as Return On Equity of -7.24, current valuation of 22.58 M, and Shares Owned By Insiders of 48.30 % as well as examining its technical indicators and probability of bankruptcy.
Nemaura Medical Total Value Analysis
Nemaura Medical is now projected to have valuation of 22.58 M with market capitalization of 2.43 M, debt of 20.03 M, and cash on hands of 14.75 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nemaura Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
22.58 M | 2.43 M | 20.03 M | 14.75 M |
Nemaura Medical Investor Information
About 48.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.39. Nemaura Medical last dividend was issued on the 5th of December 2019. The entity had 1:10 split on the 5th of December 2019. Nemaura Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Nemaura Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nemaura Medical has an asset utilization ratio of 0.53 percent. This indicates that the Company is making $0.00529 for each dollar of assets. An increasing asset utilization means that Nemaura Medical is more efficient with each dollar of assets it utilizes for everyday operations.Nemaura Medical Ownership Allocation
Nemaura Medical holds a total of 28.9 Million outstanding shares. Nemaura Medical holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. On February 15, 2022, Senator Dianne Feinstein of US Senate acquired $15k to $50k worth of Nemaura Medical's common stock.Nemaura Medical Profitability Analysis
The company reported the previous year's revenue of 77.04 K. Net Loss for the year was (14.14 M) with loss before overhead, payroll, taxes, and interest of (1.48 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nemaura Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nemaura Medical and how it compares across the competition.
Nemaura Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nemaura Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24.9 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Nemaura Pink Sheet
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |